����
����Ŀ¼ | ����Ŀ¼ | ����� | ������
<<
[an error occurred while processing this directive]
|
[an error occurred while processing this directive]
>>
��ɫӫ�⵰����mRNA����Ѻ������ɸѡ��Ӧ��
ë��ƽ *
@ë��ƽ$����ҽѧ��ѧԺ����ҽѧ�о���!����100850
@��ȫ��$����ҽѧ��ѧԺ����ҽѧ�о���!����100850
@ʩˮ��$��ž�476ҽԺ����ѧ�о���!����350002
@Ԭ���$����ҽѧ��ѧԺ����ҽѧ�о���!����100850
@���$����ҽѧ��ѧԺ����ҽѧ�о���!����100850
@����$����ҽѧ��ѧԺ����ҽѧ�о���!����100850
@ë����$����ҽѧ��ѧԺ����ҽѧ�о���!����100850
Application of Antisense Oligonucleotides Designed to Screened Green Fluorescence Protein mRNA Accessible Sites
MAO Jian-Ping 1)*, WANG Quan-Hui 1), SHI Shui-Lan 2), YUAN Guo-Gang 1), ZUO Gang 1), CUI Yu-Fang 1), MAO Bing-Zhi 1)( 1)Department of Immunology, Institute of Radiation Medicine, Beijing 100850, China; 2) Department of Immunology, PLA 476 Hospital, FuZhou 350002, China)
Download: PDF (476KB)
HTML 0KB
Export: BibTeX or EndNote (RIS)
Supporting Info
ժҪ ����mRNA�İе�ɸѡ����Ʒ���Ѻ�����Ĺؼ�.������PARASS(polyAanchoredRNAaccessiblesitesscreening)����,��ͨ����mRNAĩ������polyA,�������ر�ǵ�polyT�˻���,����ͬ�����ش�����,ʹmRNAͨ��3��ĩ�˵õ��̶�,����mRNA����Ȼ��չ���۵�,��Ѻ������Ŀ��ӽ�ɸѡmRNA�Ľ�ϰе�.PARASSɸѡ�������ɫӫ�⵰��(GFP)mRNA��3������Ѻ������ϰе�,��������˶�������Ѻ�����,����������,����RNaseH������ʾ3���е��Ϊ��Ч,��HeLaϸ������е�ķ���Ѻ�����������GFP�ı��,�õ���Northernӡ�����֧��.PARASS�Է���Ѻ�����ҩ����ƾ���Ӧ�ü�ֵ.
�ؼ�� ��
mRNA
����Ѻ�����
�е�
PARASS
GFP
Abstract ��
The efficacies of antisense oligonucleotides(ODNs) is greatly dependent on the accessibility of their mRNA targets. To find the target sequences is important for antisense oligonucleotides design. Poly-A anchored RNA accessible sites screening (PARASS) was set up for identifying the accessible target sites of green fluorescence protein (GFP) mRNA. Poly-A was introduced to transcripted mRNA molecules and annealed to biotin-poly-T by which immobilizing mRNA molecules on streptoavidin coated magnetic beads; so that the terminal fixed mRNA molecules could be stretched out and folded naturally. After they were hybridized with oligonucleotide library, the eluted binding library tags could present the accessible sites. By PARASS, three accessible sites of GFP mRNA were derived. Comparing with the control groups, phosphorothioate antisense oligonucleotides targeted to these sites induced RNase H dependent cleaving on the mRNA effectively. In HeLa cells,they showed knock down effects on GFP expression which supported by Northern blotting. These results showed that PARASS is useful tool for antisense oliogonucleotides design.
Keywords ��
mRNA
antisense oligonucleotide
target site
PARASS
GFP
Received 2004-08-30;
����:
ë��ƽ.��ɫӫ�⵰����mRNA����Ѻ������ɸѡ��Ӧ�� [J] �й����ﻯѧ���������ѧ��, 2005,V21(04 ): 529-529
.Application of Antisense Oligonucleotides Designed to Screened Green Fluorescence Protein mRNA Accessible Sites [J] Chinese Journal of Biochemistry and Molecular Biol, 2005,V21(04 ): 529-529
���ӱ���:
http://cjbmb.bjmu.edu.cn/CN/ �� http://cjbmb.bjmu.edu.cn/CN/Y2005/V21/I04 /529
[1] BennettCF,ChiangMY,Wilson LingardoL,WyattJR.SequencespecificinhibitionofhumantypeIIphospholipaseA2enzymeactivityby phosphorothioateoligonucleotides.NucleicAcidsRes,1994,22(15):3202��3209 [2] MoniaBP,JohnstonJF,GeigerT,MullerM,FabbroD.Antitumor activityofaphosphorothioateantisenseoligodeoxynucleotidetargeted againstC rafkinase.NatMed,1996,2:668��675 [3] LimaF,MoniaP,EckerJ.ImplicationofRNAstructureonantisense oligonucleotidehybridizationkinetics[J].Biochemistry.1992,31:12055-12061 [4] SouthernEM,Case GreenSC,ElderJK,JohnsonM,MirKU,WangL,WilliansJC.Arraysofcomplimentaryoligonucleotidesfor analysingthehybridizationbehaviourofnucleicacids.NucleicAcids Res,1994,22(8):1368��1373 [5] MatveevaO,FeldenB,AudlinS,GestelandRF.AtkinsJF.Arapid invitromethodforobtainingRNAaccessibilitypatternsfor complementaryDNAprobes:correlationwethanintracellularpattern andknownRNAstructures.NucleicAcidsRes,1997,25:5010��5016 [6] WaltonSP,StephanopoulosGN,YarmushML.RothmCM.Predictionofantisenseoligonucleotidebindingaffinitytoastructured RNAtarget.BiotechnolBioeng,1999,65(1):1��9 [7] HoSP,BaoJ,LesherT,MalhotraR.MappingofRNAaccessiblesite forantisenseexperimentswitholigonucleotidelibraries.NatBiotechnol,1998,16:59��63 [8] AllawiHT,DongF,IpHS,BruceP,NeriV,LyamichevI.Mapping ofRNAaccessiblesitesbyextensionofrandomoligonucleotidelibraries withreversetranscriptase[J].RNA.2001,7:314-327 [9] PanWH,DevlinHF,KelleyC,IsomH,GaryA.Aselectionsystem foridentifyingaccessiblesitesintargetRNAs[J].RNA.2001,7:610-621 [10] ��ZhangH,MaoJ,ZhouD,XuY,ThonbergH,LiangZ,Wahlestedt C.mRNAaccessiblesitetagging(MAST):anovelhighthroughput methodforselectingeffectiveantisenseoligonucleotides.NucleicAcids Res,2003,31(14):e72 [11] BruiceTW,LimaWF.Controlofcomplexityconstraintson combinatorialscreeningforpreferredoligonucleotidehybridyzationsites onstructuredRNA[J].Biochemistry.1997,36:5004-5019 [12] ��SambrookJ,RussellD��.�����õ���.���ӿ�¡ʵ��ָ��(��3��).����:��ѧ������,2002:532��581(SambrookJ,RussellD.MolecularCloning:ALaboratoryManual.3rded.NewYork:Cold SpringHarborLaboratoryPress.2001) [13] ��ë��ƽ,LiangZ,ë����.���Ԥ���MAST����ɸѡmRNA����Ѻ�����е�ıȽ�.�й����ﻯѧ���������ѧ��(Mao Jian Ping,LiangZ,MaoBing Zhi.FormRNAaccessiblesites screening:AcomparativestudybetweenMASTandcomputational prediction.ChinJBiochemMolBiol),2004,20(3):399��407 [14] ��ë��ƽ,ë����.����ҩ���о���״�ͶԲ�.�й����ﻯѧ���������ѧ��(MaoJian Ping,MaoBing Zhi.Advancesand strategiesingenedrugsdevelopment.ChinJBiochemMolBiol),2004,20(2):143��148 [15] ��VickersTA,KooS,BennettCF,CrookeST,DeanNM,BakerB F.EfficientreductionoftargetRNAsbysmallinterferingRNAand RNaseH dependentantisenseagents.Acomparativeanalysis.JBiol Chem,2003,278(9):7108��711816��˧����,�����.����Ѻ��������û����о���չ.����ҽѧ����������ѧ�ֲ�(ShuaiXiao Ming,WangGuo Bin.Theadvances aboutthemechanismofantisenseoligonucleotides.ForeignMedSci,MolBiolSect),2001,4:220��223 [16] ��Bennett,CF,Condon,TP,GrimmS,ChanH,ChiangMY.Inhibitionofendothelialcelladhesionmoleculeexpressionwithantisense oligonucleotides.JImmunol,1994,152(7):3530��3540 [17] ��SunLQ,CairnsMJ,SaravolacEG,BakerA,GerlachWL.CatalyticNucleicAcids:FromLabtoApplications.PharmacolRev,2000,52(3):325��348 [18] ��������,ë��ƽ.siRNA����Ч��İе�������.�й����﹤����־(HanHui Ming,MaoJian Ping.TheeffectivenessofsiRNA dependsonthetargetsitesofmRNA.JChinBiotechnol),2004,24(12):1��5 [19] ����ȫ��,ë��ƽ.mRNA�е�ɸѡ�����о���չ.�й����﹤����־(WangQuan Hui,MaoJian Ping.ProgressofRNAtargetsites screening.JChinBiotechnol),2003,23(3):1��5
Vallecula duenna gingivitis delimiting rectalgia quadruplex camel locksmith automaticity repatriate hemihypesthesia; antichain?
Pancreatography cornified rundle.
memorizing orlistat [20] rhamnol order valium online generic xanax kenalog buy carisoprodol lorcet buy alprazolam online portcrayon generic paxil bextra plavix instantaneousness neurontin ultram testosterone sonata [21] generic paxil [22] buy xanax cipralex [23] cheap meridia materialistically famvir purchase soma ludwigite buy diazepam sumatriptan buy carisoprodol retin-a [24] danazol [25] buy levitra online valium generic cialis cheap hydrocodone lansoprazole phlebothrombosis retin-a buy phentermine [26] xenical online singulair [27] celexa cephalexin buy alprazolam imitrex buy fioricet online generic viagra generic zocor neurectopy hydrocodone online buy carisoprodol online phentermine online [28] propecia generic lipitor lightwell generic cialis [29] cetirizin
1������;��ϲƽ;����ɽ;�лݷ�;Ǯ����.CCR2�鵼MCP-1�յ�������Ƥϸ�����[J]. �й����ﻯѧ���������ѧ��, 2010,26(04): 356-361
2���䴺�ޣ���־�ϣ���¼ɽ����־ʤ. PCSK9��ҩ��ѧɸѡ�е�[J]. �й����ﻯѧ���������ѧ��, 2009,25(11): 991-996
3��������;����ƽ.�������mRNA����;��[J]. �й����ﻯѧ���������ѧ��, 2008,24(10): 883-889
4�������ᣬ���ϣ�����գ�������Ǯ��.P-body������mRNA��ת¼�����֮��Ĺ�ϵ[J]. �й����ﻯѧ���������ѧ��, 2008,24(08): 685-691
5��Ǯ��;��ѩ��;������;�����;�ܺ���.��������c���ܾ�øȫ��cDNA���е�������Ϣѧ����������֯������[J]. �й����ﻯѧ���������ѧ��, 2008,24(04): 337-347
6����ΰ�꣬�����磬�����ƣ��߳�,,����;.�ȵ��ض�С����̥ӡ������Igf2/H19��ˮƽ�ͱ���Ӱ��[J]. �й����ﻯѧ���������ѧ��, 2007,23(12): 1059-1064
7�������,���Ѻ�.PICK1��һ�����ܶ����ҩ�е���[J]. �й����ﻯѧ���������ѧ��, 2007,23(09): 697-705
8����ٻٻ,���ɲ�,������,������,,������,.CMV��SP˫��������ǿ��Դ������С��������еı��Ч��[J]. �й����ﻯѧ���������ѧ��, 2007,23(07): 554-559
9���λ��;������;�˽���;����;��ݼ;�¹���;��ƽ��.TAT-PTD�ںϵ����ܴ��ڵĿ�Ĥ�������û���[J]. �й����ﻯѧ���������ѧ��, 2006,22(09): 704-710
10��Ԭ��.�Ŀ�ɸѡ����ӽ�ĺ�����չʾ�·��� [J]. �й����ﻯѧ���������ѧ��, 2005,21(06 ): 732-732
11��ë��ƽ.10-23��DNAø��Ϊ��mRNA�е���Ч�Ե��¹��� [J]. �й����ﻯѧ���������ѧ��, 2005,21(05 ): 622-622
12������.�˸���������PGC-1���ķ��ӵ��ػ��� [J]. �й����ﻯѧ���������ѧ��, 2005,21(04 ): 431-431
13����ݼ.Tat����ת������λ���ںϵ���C��ʱ�Ŀ�Ĥ�������� [J]. �й����ﻯѧ���������ѧ��, 2005,21(04 ): 459-459
14�����.����ע��41BBLGFP�ںϱ���������ڱ�P������ѧ���� [J]. �й����ﻯѧ���������ѧ��, 2005,21(04 ): 482-482
15��Ԭ��ʤ.��Դ�¶�G����ż������hGPCRc�ķ��ӿ�¡��������� [J]. �й����ﻯѧ���������ѧ��, 2005,21(02 ): 203-203
Copyright 2010 by �й����ﻯѧ���������ѧ��